Innovation With Broader Reach
Cystic Fibrosis Therapeutic Innovation That Benefits As Many Patients As Possible
A comprehensive and accessible approach to the treatment of cystic fibrosis.
Our Patented Family of Molecules
Our patented family of molecules has a mechanism of action that opens new horizons in the treatment of Cystic Fibrosis.
We aim to treat cystic fibrosis beyond its respiratory symptoms and provide access to treatment to every patient suffering from the disease.
Proven Preclinical Efficacy
The VG2D Pharma molecules underwent multiple proof of concept experiments in vivo and in vitro. The latter confirmed the mechanism of action, the efficacy and the safety of this family of molecules in the treatment of cystic fibrosis beyond respiratory symptoms.
Our ambition is to improve patient experience with cystic fibrosis treatments. For that purpose, our treatment is an oral pill to be taken anytime during the day. Such dosing is intended to decrease the burden of the pill and improve adherence.
Dr. Imane Wild
Dr. Frédéric Velard
Prof. Stéphane Gérard
Meet the dedicated minds behind VG2D Pharma. Passionate, innovative, and driven to redefine the boundaries of healthcare.
Together We Achieve
A Collaborative Approach
We collaborate with public and private institutions to deliver first-class solutions in rare diseases and beyond.